678 related articles for article (PubMed ID: 34514087)
1. Nanotechnology-Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID-19 Vaccines.
Rinoldi C; Zargarian SS; Nakielski P; Li X; Liguori A; Petronella F; Presutti D; Wang Q; Costantini M; De Sio L; Gualandi C; Ding B; Pierini F
Small Methods; 2021 Sep; 5(9):e2100402. PubMed ID: 34514087
[TBL] [Abstract][Full Text] [Related]
2. Complex Coacervates as a Promising Vehicle for mRNA Delivery: A Comprehensive Review of Recent Advances and Challenges.
Forenzo C; Larsen J
Mol Pharm; 2023 Sep; 20(9):4387-4403. PubMed ID: 37561647
[TBL] [Abstract][Full Text] [Related]
3. Critical review of nucleic acid nanotechnology to identify gaps and inform a strategy for accelerated clinical translation.
Afonin KA; Dobrovolskaia MA; Ke W; Grodzinski P; Bathe M
Adv Drug Deliv Rev; 2022 Feb; 181():114081. PubMed ID: 34915069
[TBL] [Abstract][Full Text] [Related]
4. Nanosize drug delivery system.
Mukherjee B
Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
[TBL] [Abstract][Full Text] [Related]
5. MATra - Magnet Assisted Transfection: combining nanotechnology and magnetic forces to improve intracellular delivery of nucleic acids.
Bertram J
Curr Pharm Biotechnol; 2006 Aug; 7(4):277-85. PubMed ID: 16918404
[TBL] [Abstract][Full Text] [Related]
6. Nucleic acid-based drug delivery strategies.
Tan X; Jia F; Wang P; Zhang K
J Control Release; 2020 Jul; 323():240-252. PubMed ID: 32272123
[TBL] [Abstract][Full Text] [Related]
7. Nucleic Acid Nanotechnology: Trends, Opportunities and Challenges.
Singh RP; Srivastava AK; Yang YJ; Manchanda G; Kumar A; Yerpude ST; Rai AR; Dubey RC
Curr Pharm Biotechnol; 2023; 24(1):50-60. PubMed ID: 35619298
[TBL] [Abstract][Full Text] [Related]
8. Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.
Dobrovolskaia MA; McNeil SE
Expert Opin Drug Deliv; 2015 Jul; 12(7):1163-75. PubMed ID: 25994601
[TBL] [Abstract][Full Text] [Related]
9. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.
Xu L; Anchordoquy T
J Pharm Sci; 2011 Jan; 100(1):38-52. PubMed ID: 20575003
[TBL] [Abstract][Full Text] [Related]
10. Application of vinyl polymer-based materials as nucleic acids carriers in cancer therapy.
Pereira PA; Serra MES; Serra AC; Coelho JFJ
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Sep; 14(5):e1820. PubMed ID: 35637638
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology-Based RNA Vaccines: Fundamentals, Advantages and Challenges.
Pozharov VP; Minko T
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678823
[TBL] [Abstract][Full Text] [Related]
12. Stimuli-Responsive Nanotechnology for RNA Delivery.
Zhou H; Chen DS; Hu CJ; Hong X; Shi J; Xiao Y
Adv Sci (Weinh); 2023 Dec; 10(36):e2303597. PubMed ID: 37915127
[TBL] [Abstract][Full Text] [Related]
13. Emerging nanotechnology role in the development of innovative solutions against COVID-19 pandemic.
Bhutta ZA; Kanwal A; Ali M; Kulyar MF; Yao W; Shoaib M; Ashar A; Mahfooz A; Ijaz M; Ijaz N; Asif M; Nawaz S; Mahfooz MR; Kanwal T
Nanotechnology; 2021 Sep; 32(48):. PubMed ID: 34320471
[TBL] [Abstract][Full Text] [Related]
14. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
Grumezescu AM; Chifiriuc CM
Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
[TBL] [Abstract][Full Text] [Related]
15. ncRNAs in Therapeutics: Challenges and Limitations in Nucleic Acid-Based Drug Delivery.
Hueso M; Mallén A; Suñé-Pou M; Aran JM; Suñé-Negre JM; Navarro E
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769025
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-Mediated Cytoplasmic Delivery of Messenger RNA Vaccines: Challenges and Future Perspectives.
Wu Z; Li T
Pharm Res; 2021 Mar; 38(3):473-478. PubMed ID: 33660201
[TBL] [Abstract][Full Text] [Related]
17. Insights into nucleic acid-based self-assembling nanocarriers for targeted drug delivery and controlled drug release.
Chen K; Zhang Y; Zhu L; Chu H; Shao X; Asakiya C; Huang K; Xu W
J Control Release; 2022 Jan; 341():869-891. PubMed ID: 34952045
[TBL] [Abstract][Full Text] [Related]
18. Nanotechnology-Based Strategies for the Management of COVID-19: Recent Developments and Challenges.
Singh R; Behera M; Kumari N; Kumar S; Rajput VD; Minkina TM; Adnan M; Siddiqui AJ; Kumar N
Curr Pharm Des; 2021; 27(41):4197-4211. PubMed ID: 34459371
[TBL] [Abstract][Full Text] [Related]
19. Nanotechnology-Driven Delivery Systems in Inoculation Therapies.
Pereira GC
Methods Mol Biol; 2023; 2575():39-57. PubMed ID: 36301470
[TBL] [Abstract][Full Text] [Related]
20. Advanced Formulation Approaches for Emerging Therapeutic Technologies.
Allahham N; Colic I; Rayner MLD; Gurnani P; Phillips JB; Rahim AA; Williams GR
Handb Exp Pharmacol; 2024; 284():343-365. PubMed ID: 37733107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
